Joanna Szkandera

4.5k total citations · 1 hit paper
99 papers, 3.3k citations indexed

About

Joanna Szkandera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Joanna Szkandera has authored 99 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 52 papers in Pulmonary and Respiratory Medicine and 30 papers in Surgery. Recurrent topics in Joanna Szkandera's work include Sarcoma Diagnosis and Treatment (47 papers), Inflammatory Biomarkers in Disease Prognosis (17 papers) and Vascular Tumors and Angiosarcomas (15 papers). Joanna Szkandera is often cited by papers focused on Sarcoma Diagnosis and Treatment (47 papers), Inflammatory Biomarkers in Disease Prognosis (17 papers) and Vascular Tumors and Angiosarcomas (15 papers). Joanna Szkandera collaborates with scholars based in Austria, United States and Germany. Joanna Szkandera's co-authors include Armin Gerger, Martin Pichler, Michael Stotz, Tatjana Stojaković, Gudrun Absenger, Andreas Leithner, Hellmut Samonigg, Bernadette Liegl‐Atzwanger, Renate Schaberl-Moser and H. Samonigg and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Joanna Szkandera

96 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

2013 413 citations Michael Stotz, Armin Gerger et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanna Szkandera Austria	29	2.3k	1.1k	920	736	420	99	3.3k
Michael Stotz Austria	28	2.2k 0.9×	738 0.7×	845 0.9×	901 1.2×	553 1.3×	71	3.1k
Hyo Song Kim South Korea	34	1.8k 0.8×	2.0k 1.9×	809 0.9×	536 0.7×	875 2.1×	182	3.7k
Jy‐Ming Chiang Taiwan	31	2.2k 0.9×	565 0.5×	1.6k 1.7×	308 0.4×	300 0.7×	117	3.3k
Jyrki Mäkelä Finland	36	2.5k 1.1×	826 0.8×	2.4k 2.6×	370 0.5×	360 0.9×	130	4.5k
Hiroshi Kawachi Japan	34	1.2k 0.5×	1.0k 1.0×	1.0k 1.1×	246 0.3×	789 1.9×	157	3.2k
Florian Posch Austria	31	1.2k 0.5×	675 0.6×	656 0.7×	375 0.5×	451 1.1×	136	3.6k
Gennaro Galizia Italy	43	2.8k 1.2×	1.9k 1.8×	1.3k 1.4×	910 1.2×	1.2k 2.8×	140	5.2k
Peter Kornprat Austria	30	2.9k 1.2×	925 0.9×	1.7k 1.9×	528 0.7×	397 0.9×	109	4.1k
Eva Lieto Italy	31	1.7k 0.7×	1.1k 1.1×	868 0.9×	443 0.6×	625 1.5×	67	3.1k

Countries citing papers authored by Joanna Szkandera

Since Specialization

Citations

This map shows the geographic impact of Joanna Szkandera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Szkandera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Szkandera more than expected).

Fields of papers citing papers by Joanna Szkandera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Szkandera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Szkandera. The network helps show where Joanna Szkandera may publish in the future.

Co-authorship network of co-authors of Joanna Szkandera

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Szkandera. A scholar is included among the top collaborators of Joanna Szkandera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Szkandera. Joanna Szkandera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smolle, Maria Anna, et al.. (2025). Incidence of and survival with bone and soft tissue sarcoma: A nation‐wide study over four decades. Cancer Communications. 45(4). 397–400. 1 indexed citations

Smolle, Maria Anna, Dimosthenis Andreou, Susanne Scheipl, et al.. (2023). Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study. Cancers. 15(6). 1733–1733. 6 indexed citations

Szkandera, Joanna. (2022). Keeping up the ‘race pace’ in a patient with nonuterine leiomyosarcoma. Future Oncology. 18(sup29). 12–16. 2 indexed citations

Barth, Dominik A., Stefanie Stanzer, Thomas Bauernhofer, et al.. (2022). Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study. Frontiers in Immunology. 13. 840207–840207. 18 indexed citations

Smolle, Maria Anna, Iva Brčić, Marko Bergovec, et al.. (2021). T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study. British Journal of Cancer. 125(5). 717–724. 22 indexed citations

Praag, Veroniek M. van, Desirée M. J. Dorleijn, Cornelis Verhoef, et al.. (2021). Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly. European Journal of Surgical Oncology. 48(5). 985–993. 4 indexed citations

Smolle, Maria Anna, Michiel A. J. van de Sande, Andrew Hayes, et al.. (2021). Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres. European Journal of Surgical Oncology. 47(8). 2182–2188. 3 indexed citations

Gilg, Magdalena M., Lukas Leitner, Marko Bergovec, et al.. (2020). Tumor-associated mortality and prognostic factors in myxofibrosarcoma – A retrospective review of 109 patients. Orthopaedics & Traumatology Surgery & Research. 106(6). 1059–1065. 16 indexed citations

Aziz, Faisal, Jakob M. Riedl, Florian Posch, et al.. (2020). Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients. Scientific Reports. 10(1). 12438–12438. 2 indexed citations

10.

Barth, Dominik A., Julia Riedl, Florian Posch, et al.. (2019). Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study. Clinical & Translational Oncology. 21(8). 1034–1043. 3 indexed citations

11.

Brčić, Iva, Thomas Brodowicz, Lorenzo Cerroni, et al.. (2019). Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum. Pathology. 52(2). 236–242. 26 indexed citations

12.

Terbuch, Angelika, Florian Posch, Thomas Bauernhofer, et al.. (2018). Risk stratification for febrile neutropenia in patients with testicular germ cell tumors. Cancer Medicine. 7(2). 508–514. 12 indexed citations

13.

Szkandera, Joanna, Tatjana Stojaković, Peter Kornprat, et al.. (2018). Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer. Wiener klinische Wochenschrift. 130(19-20). 569–574. 2 indexed citations

14.

Riedl, Jakob M., Florian Posch, Florian Moik, et al.. (2017). Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting. Oncotarget. 8(56). 96048–96061. 23 indexed citations

15.

Szkandera, Joanna, Sereina A. Herzog, Martin Pichler, et al.. (2015). LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy. The Pharmacogenomics Journal. 15(5). 391–396. 12 indexed citations

16.

Szkandera, Joanna, Armin Gerger, Bernadette Liegl‐Atzwanger, et al.. (2014). Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients. PLoS ONE. 9(9). e107297–e107297. 32 indexed citations

17.

Absenger, Gudrun, Joanna Szkandera, Michael Stotz, et al.. (2013). A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early‐stage breast cancer. Molecular Carcinogenesis. 52(S1). 96–102. 12 indexed citations

18.

Szkandera, Joanna, Martin Pichler, Bernadette Liegl‐Atzwanger, et al.. (2013). The elevated pre‐operative plasma fibrinogen level is an independent negative prognostic factor for cancer‐specific, disease‐free and overall survival in soft‐tissue sarcoma patients. Journal of Surgical Oncology. 109(2). 139–144. 20 indexed citations

19.

Szkandera, Joanna, Tobias Kiesslich, Johannes Haybaeck, Armin Gerger, & Martin Pichler. (2013). Hedgehog Signaling Pathway in Ovarian Cancer. International Journal of Molecular Sciences. 14(1). 1179–1196. 50 indexed citations

20.

Richtig, Erika, Armin Gerger, Laila El‐Shabrawi‐Caelen, Joanna Szkandera, & Rainer Hofmann‐Wellenhof. (2009). Reflectance confocal microscopy in early diagnosis of cutaneous metastases of breast cancer. Gynecologic Oncology. 115(3). 510–511. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact